Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,996,338
+$112,435 QoQ
Shares Held
11,798
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.48%
of 13F equity value
Holder Rank
#2,008
of 4,664 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bradyco, Inc. holds $3,911,739 across 2 Drug Manufacturers - General names. JNJ ranks #1 (76.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
11,798 | $2,996,338 | |
| 2 | NVS |
Novartis AG
|
5,841 | $915,401 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,996,338 | 11,798 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,883,903 | 11,798 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,441,596 | 11,798 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,187,585 | 11,798 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,802,144 | 11,798 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,956,580 | 11,798 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,817,439 | 12,567 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||